Mark A. Velleca - 25 May 2021 Form 4 Insider Report for G1 Therapeutics, Inc.

Role
Director
Signature
/s/ James Stillman Hanson, attorney-in-fact
Issuer symbol
N/A
Transactions as of
25 May 2021
Net transactions value
+$7,800
Form type
4
Filing time
25 May 2021, 18:29:34 UTC
Previous filing
13 May 2021
Next filing
17 Jun 2021
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction GTHX Common Stock Options Exercise $7,800 +20,000 +49% $0.3900* 61,000 25 May 2021 Direct

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction GTHX Stock Options (Right to Buy) Options Exercise $0 -20,000 -6.5% $0.000000 287,286 25 May 2021 Common Stock 20,000 $0.3900 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 All shares underlying this option have vested.